| Literature DB >> 25651181 |
Fabio R Santori1, Pengxiang Huang2, Serge A van de Pavert3, Eugene F Douglass4, David J Leaver5, Brad A Haubrich5, Rok Keber6, Gregor Lorbek7, Tanja Konijn3, Brittany N Rosales5, Damjana Rozman7, Simon Horvat8, Alain Rahier9, Reina E Mebius3, Fraydoon Rastinejad2, W David Nes5, Dan R Littman10.
Abstract
Mice deficient in the nuclear hormone receptor RORγt have defective development of thymocytes, lymphoid organs, Th17 cells, and type 3 innate lymphoid cells. RORγt binds to oxysterols derived from cholesterol catabolism, but it is not clear whether these are its natural ligands. Here, we show that sterol lipids are necessary and sufficient to drive RORγt-dependent transcription. We combined overexpression, RNAi, and genetic deletion of metabolic enzymes to study RORγ-dependent transcription. Our results are consistent with the RORγt ligand(s) being a cholesterol biosynthetic intermediate (CBI) downstream of lanosterol and upstream of zymosterol. Analysis of lipids bound to RORγ identified molecules with molecular weights consistent with CBIs. Furthermore, CBIs stabilized the RORγ ligand-binding domain and induced coactivator recruitment. Genetic deletion of metabolic enzymes upstream of the RORγt-ligand(s) affected the development of lymph nodes and Th17 cells. Our data suggest that CBIs play a role in lymphocyte development potentially through regulation of RORγt.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25651181 PMCID: PMC4317570 DOI: 10.1016/j.cmet.2015.01.004
Source DB: PubMed Journal: Cell Metab ISSN: 1550-4131 Impact factor: 27.287